
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Author(s) -
N. M. Archin,
A. L. Liberty,
A. D. Kashuba,
Smriti Choudhary,
J. D. Kuruc,
A. M. Crooks,
D. C. Parker,
E. M. Anderson,
M. F. Kearney,
M. C. Strain,
D. D. Richman,
M. G. Hudgens,
R. J. Bosch,
J. M. Coffin,
J. J. Eron,
D. J. Hazuda,
D. M. Margolis
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/18v5-mv62
Subject(s) - antiretroviral therapy , vorinostat , human immunodeficiency virus (hiv) , medicine , latency (audio) , virology , oncology , viral load , biology , computer science , telecommunications , histone deacetylase , gene , histone , biochemistry